{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:23:24Z","timestamp":1785371004496,"version":"3.55.0"},"reference-count":35,"publisher":"Japanese Circulation Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2026,4,24]]},"DOI":"10.1253\/circj.cj-25-0808","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T22:09:03Z","timestamp":1774390143000},"page":"515-521","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Ability of the Japanese Version of the High Bleeding Risk Criteria in Patients With Lower Extremity Peripheral Arterial Disease"],"prefix":"10.1253","volume":"90","author":[{"given":"Tadahiro","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Cardiology, Chibaken Saiseikai Narashino Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Narita Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikiyo","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Funabashi Municipal Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Takahara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kimitsu Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakuramaru","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japan Community Health Organization Chiba Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raita","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japan Community Health Organization Chiba Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chibaken Saiseikai Narashino Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Funabashi Municipal Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chibaken Saiseikai Narashino Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis. <i>Nat Rev Dis Primers<\/i> 2019; 5: 56.","DOI":"10.1038\/s41572-019-0106-z"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Magnussen C, Ojeda FM, Leong DP, Alegre-Diaz J, Amouyel P, Aviles-Santa L, et al. Global effect of modifiable risk factors on cardiovascular disease and mortality. <i>N Engl J Med<\/i> 2023; 389: 1273\u20131285.","DOI":"10.1056\/NEJMoa2206916"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Saito Y, Tateishi K, Kato K, Kitahara H, Kobayashi Y. Standard and non-standard cardiovascular risk factors in ischemic heart disease and atherosclerotic cardiovascular disease: A clinical review. <i>Intern Med<\/i> 2026; 65: 508\u2013519.","DOI":"10.2169\/internalmedicine.5950-25"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Alberts MJ, Bhatt DL, Mas JL, Ohman EM, Hirsch AT, R\u00f6ther J, et al. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. <i>Eur Heart J<\/i> 2009; 30: 2318\u20132326.","DOI":"10.1093\/eurheartj\/ehp355"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. <i>Eur Heart J<\/i> 2024; 45: 3538\u20133700.","DOI":"10.1093\/eurheartj\/ehae179"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nakamura M, Kimura K, Kimura T, Ishihara M, Otsuka F, Kozuma K, et al. JCS 2020 Guideline focused update on antithrombotic therapy in patients with coronary artery disease. <i>Circ J<\/i> 2020; 84: 831\u2013865.","DOI":"10.1253\/circj.CJ-19-1109"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: A consensus document from the Academic Research Consortium for High Bleeding Risk. <i>Eur Heart J<\/i> 2019; 40: 2632\u20132653.","DOI":"10.1093\/eurheartj\/ehz372"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. <i>Eur Heart J<\/i> 2024; 45: 3415\u20133537.","DOI":"10.1093\/eurheartj\/ehae177"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yoshioka N, Takagi K, Morita Y, Kanzaki Y, Nagai H, Watanabe N, et al. Bleeding events and mid-term mortality in the patients undergoing endovascular interventions for peripheral artery disease of the lower limbs based on the Academic Research Consortium High Bleeding Risk criteria. <i>Heart Vessels<\/i> 2021; 36: 1336\u20131349.","DOI":"10.1007\/s00380-021-01804-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hashimoto R, Numasawa Y, Yokokura S, Daigo K, Sakata S, Imaeda S, et al. Prevalence of the Academic Research Consortium High Bleeding Risk criteria in patients undergoing endovascular therapy for peripheral artery disease in lower extremities. <i>Heart Vessels<\/i> 2021; 36: 1350\u20131358.","DOI":"10.1007\/s00380-021-01813-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tomoi Y, Kuramitsu S, Shinozaki T, Soga Y, Kodama K, Imada K, et al. Validation of the Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria in patients undergoing peripheral endovascular interventions. <i>EuroIntervention<\/i> 2023; 18: e1368\u2013e1377.","DOI":"10.4244\/EIJ-D-22-00475"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yoshioka N, Tokuda T, Koyama A, Yamada T, Shimamura K, Nishikawa R, et al. Association between high bleeding risk and 2-year mortality in patients with chronic limb-threatening ischemia. <i>J Atheroscler Thromb<\/i> 2023; 30: 1674\u20131686.","DOI":"10.5551\/jat.64157"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shima Y, Taninobu N, Ikuta A, Mushiake K, Tanaka H, Kadota K. Two-year outcomes of endovascular therapy for femoropopliteal arterial lesions for patients with high bleeding risk. <i>Cardiovasc Interv Ther<\/i> 2024; 39: 284\u2013292.","DOI":"10.1007\/s12928-024-00999-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yoshioka N, Tokuda T, Koyama A, Yamada T, Shimamura K, Nishikawa R, et al. Clinical outcomes based on high bleeding risk in patients with lower extremity peripheral artery disease who have undergone endovascular therapy. <i>J Endovasc Ther<\/i> 2025; 32: 439\u2013451.","DOI":"10.1177\/15266028231176953"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Levine GN, Jeong YH, Goto S, Anderson JL, Huo Y, Mega JL, et al. Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. <i>Nat Rev Cardiol<\/i> 2014; 11: 597\u2013606.","DOI":"10.1038\/nrcardio.2014.104"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yamamoto K, Saito Y, Ohno Y, Oka N, Takahara M, Suzuki S, et al. Validation of high ischemic and bleeding risk criteria of European guidelines in peripheral arterial disease. <i>JACC Asia<\/i> 2025; 5: 744\u2013754.","DOI":"10.1016\/j.jacasi.2025.01.018"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Saito Y, Ohno Y, Yamamoto K, Oka N, Takahara M, Suzuki S, et al. Comparable clinical characteristics and outcomes of patients undergoing endovascular treatment for aorto-iliac or femoropopliteal lesions. <i>Cardiovasc Interv Ther<\/i> 2025; 40: 852\u2013859, doi:10.1007\/s12928-025-01143-4.","DOI":"10.1007\/s12928-025-01143-4"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yu A, Fujimura N, Hayashi M, Harada H. Hybrid treatment of distal bypass and pedal artery angioplasty following intraoperative direct puncture angiography for chronic limb-threatening ischemia with occult vessel. <i>Cardiovasc Interv Ther<\/i> 2025; 39: 91\u201392.","DOI":"10.1007\/s12928-023-00948-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kodama T, Kuwabara M, Ueshima D, Yamaguchi T, Fujimoto Y, Miyazaki T, et al. Impact of intravascular ultrasound on limb events in endovascular therapy for patients with peripheral arterial disease: Insights from the TOMA-CODE registry. <i>Cardiovasc Interv Ther<\/i> 2025; 40: 344\u2013351.","DOI":"10.1007\/s12928-024-01079-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Shima Y, Taninobu N, Ikuta A, Mushiake K, Tanaka H, Kadota K. Clinical outcome of low-dose and high-dose drug-coated balloon angioplasty with intraplaque wiring for femoropopliteal chronic total occlusion lesions. <i>Cardiovasc Interv Ther<\/i> 2025; 40: 337\u2013343.","DOI":"10.1007\/s12928-024-01067-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Iwata Y, Takahara M, Tobita K, Hayakawa N, Mori S, Horie K, et al. Retrospective analysis on diameters of drug-coated balloons and predilatation balloons in infra-inguinal endovascular treatment (RABBIT study). <i>Cardiovasc Interv Ther<\/i> 2024; 39: 293\u2013301.","DOI":"10.1007\/s12928-024-01001-9"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shinozaki N, Iwasaki Y, Doi H, Imoto Y, Ikari Y. Results from a multicenter retrospective study of transradial iliac artery stenting in Japan. <i>Cardiovasc Interv Ther<\/i> 2025; 40: 89\u201394.","DOI":"10.1007\/s12928-024-01026-0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nakamura M, Kadota K, Nakao K, Nakagawa Y, Shite J, Yokoi H, et al. High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: The PENDULUM registry. <i>EuroIntervention<\/i> 2021; 16: 1154\u20131162.","DOI":"10.4244\/EIJ-D-20-00345"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Matsumoto T, Saito Y, Sato T, Yamashita D, Suzuki S, Saito K, et al. Validation of the domestic high bleeding risk criteria for Japanese patients with acute myocardial infarction. <i>J Atheroscler Thromb<\/i> 2023; 30: 299\u2013309.","DOI":"10.5551\/jat.63576"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. <i>Circulation<\/i> 2011; 123: 2736\u20132747.","DOI":"10.1161\/CIRCULATIONAHA.110.009449"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, et al. Rivaroxaban in peripheral artery disease after revascularization. <i>N Engl J Med<\/i> 2020; 382: 1994\u20132004.","DOI":"10.1056\/NEJMoa2000052"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, et al. 2017 cardiovascular and stroke endpoint definitions for clinical trials. <i>Circulation<\/i> 2018; 137: 961\u2013972.","DOI":"10.1161\/CIRCULATIONAHA.117.033502"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Lakhter V, Weinberg MD, Galmer A, Mishra S, Dalsania R, Das S, et al. Objective outcome measures for trials in patients with chronic limb-threatening ischemia across 2 decades: Analysis and recommendations. <i>JACC Cardiovasc Interv<\/i> 2021; 14: 2584\u20132597.","DOI":"10.1016\/j.jcin.2021.08.079"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, et al. 2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the management of lower extremity peripheral artery disease: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2024; 83: 2497\u20132604.","DOI":"10.1161\/CIR.0000000000001251"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Natsuaki M, Morimoto T, Shiomi H, Ehara N, Taniguchi R, Tamura T, et al. Application of the modified high bleeding risk criteria for Japanese patients in an all-comers registry of percutaneous coronary intervention: From the CREDO-Kyoto Registry Cohort-3. <i>Circ J<\/i> 2021; 85: 769\u2013781.","DOI":"10.1253\/circj.CJ-20-0836"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ueki Y, B\u00e4r S, Losdat S, Otsuka T, Zanchin C, Zanchin T, et al. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores. <i>EuroIntervention<\/i> 2020; 16: 371\u2013379.","DOI":"10.4244\/EIJ-D-20-00052"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Hageman SHJ, de Borst GJ, Dorresteijn JAN, Bots ML, Westerink J, Asselbergs FW, et al. Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular disease. <i>Heart<\/i> 2020; 106: 1686\u20131692.","DOI":"10.1136\/heartjnl-2019-316088"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Matsumoto T, Saito Y, Sato T, Yamashita D, Suzuki S, Saito K, et al. Diagnostic ability of Japanese version of high bleeding risk criteria for ischemic outcomes in patients with acute myocardial infarction. <i>Heart Vessels<\/i> 2024; 39: 1\u20139.","DOI":"10.1007\/s00380-023-02303-3"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Sasaki K, Sawayama Y, Taninobu N, Mushiake K, Matsushita S, Shima Y, et al. Impact of calcification location in the left main coronary artery bifurcation on short-term prognosis after left main stenting. <i>Circ J<\/i> 2025; 89: 1129\u20131136.","DOI":"10.1253\/circj.CJ-25-0028"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Endo K, Tanaka M, Sato T, Inyaku M, Nakata K, Kawaharata W, et al. High level of estimated small dense low-density lipoprotein cholesterol as an independent risk factor for the development of ischemic heart disease regardless of low-density lipoprotein cholesterol level: A 10-year cohort study. <i>Circ J<\/i> 2025; 89: 1182\u20131189.","DOI":"10.1253\/circj.CJ-24-0770"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/5\/90_CJ-25-0808\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T03:19:00Z","timestamp":1777087140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/5\/90_CJ-25-0808\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-25-0808","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"CJ-25-0808"}}